View More View Less
  • 1 Department of Rehabilitation, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Abstract

In this study, the ability of microRNA-1906 (miR-1906) to attenuate bone loss in osteoporosis was evaluated by measuring the effects of a miR-1906 mimic and inhibitor on the cellular toxicity and cell viability of MC3T3‐E1 cells. Bone marrow-derived macrophage (BMM) cells were isolated from female mice, and tartrate-resistant acid phosphatase signalling was performed in miR-1906 mimic-treated, receptor-activated nuclear factor kappa-B (NF-κB) ligand (RANKL)-induced osteoclasts. In-vivo, osteoporosis was induced by ovariectomy (OVX). Rats were treated with 500 nmol/kg of the miR-1906 mimic via intrathecal administration for 10 consecutive days following surgery. The effect of the miR-1906 mimic on bone mineral density (BMD) in OVX rats was observed in the whole body, lumbar vertebrae and femur. Levels of biochemical parameters and cytokines in the serum of miR-1906 mimic-treated OVX rats were analysed. The mRNA expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response 88 (MyD88), p-38 and NF-κB in tibias of osteoporotic rats (induced by ovariectomy) was observed using quantitative reverse-transcription polymerase chain reaction. Treatment with the miR-1906 mimic reduced cellular toxicity and enhanced the cell viability of MC3T3‐E1 cells. Furthermore, osteoclastogenesis in miR-1906 mimic-treated, RANKL-induced osteoclast cells was reduced, whereas the BMD in the miR-1906 mimic-treated group was higher than in the OVX group of rats. Treatment with the miR-1906 mimic also increased levels of biochemical parameters and cytokines in the serum of ovariectomised rats. Finally, mRNA expression levels of TLR4, MyD88, p-38 and NF-κB were lower in the tibias of miR-1906 mimic-treated rats than in those of OVX rats. In conclusion, the miR-1906 mimic reduces bone loss in rats with ovariectomy-induced osteoporosis by regulating the TLR4/MyD88/NF‐κB pathway.

  • 1.

    Office of the Surgeon General (US). Bone health and osteoporosis: a report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004.

    • Search Google Scholar
    • Export Citation
  • 2.

    Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 2000; 106: 12031204.

  • 3.

    Ji M-X, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med 2015; 1: 913.

  • 4.

    Zhao R. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective. Int J Med Sci 2012; 9: 825832.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab 2012; 23: 576581.

  • 6.

    Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol 2011; 6: 121145.

  • 7.

    Alonso-Pérez A, Franco-Trepat E, Guillán-Fresco M, Jorge-Mora A, López V, Pino J, et al. . Role of toll-like receptor 4 on osteoblast metabolism and function. Front Physiol 2018; 9: 504.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Geng Q, Gao H, Yang R, Guo K, Miao D. Pyrroloquinoline quinone prevents estrogen deficiency-Induced osteoporosis by inhibiting oxidative stress and osteocyte senescence. Int J Biol Sci 2019; 15: 5868.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Fröhlich L. MicroRNAs at the interface between osteogenesis and angiogenesis as targets for bone regeneration. Cells 2019; 8: 121.

  • 10.

    Fang X, Zhou H, Huang S, Liu J. MiR-1906 attenuates neuropathic pain in rats by regulating the TLR4/mTOR/Akt signaling pathway. Transl Neurosci 2019; 10: 175179.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Xu X, Wen Z, Zhao N, Xu X, Wang F, Gao J, et al. . MicroRNA-1906, a novel regulator of toll-like receptor 4, ameliorates ischemic injury after experimental stroke in mice. J Neurosci 2017; 37: 1049810515.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Kim JL, Moon CW, Son YS, Kim SJ. Combined effect of bilateral ovariectomy and anterior cruciate ligament transection with medial meniscectomy on the development of osteoarthritis model. Ann Rehabil Med 2016; 40: 583.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 2014; 142: 155170.

  • 14.

    Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res 2013; 92: 860867.

  • 15.

    Paul T, Shetty S, Kapoor N, Bondu J, Thomas N. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian J Endocrinol Metab 2016; 20: 846.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Weitzmann MN. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006; 116: 11861194.

  • 17.

    Mouihate A. TLR4-mediated brain inflammation halts neurogenesis: impact of hormonal replacement therapy. Front Cell Neurosci 2014; 8.

  • 18.

    Sato N, Takahashi N, Suda K, Nakamura M, Yamaki M, Ninomiya T, et al. . MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med 2004; 200: 601611.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Putnam NE, Fulbright LE, Curry JM, Ford CA, Petronglo JR, Hendrix AS, et al. . MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis. PLoS Pathog 2019; 15: e1007744.

    • Crossref
    • Search Google Scholar
    • Export Citation

 

 

The author instruction is available in PDF.

Please, download the file from HERE

 

 

Senior editors

Editor(s)-in-Chief: Rosivall, László

Managing Editor: Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor; Radák, Zsolt

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

  • Benedek, György (Szeged)
  • Benyó, Zoltán (Budapest)
  • Boros, Mihály (Szeged)
  • Chernoch, László (Debrecen)
  • Détári, László (Budapest)
  • Giricz, Zoltán (Budapest)
  • Hamar, János (Budapest)
  • Hantos, Zoltán (Szeged)
  • Hunyady, László (Budapest)
  • Jancsó, Gábor (Szeged)
  • Karádi, Zoltán (Pécs)
  • Palkovits, Miklós (Budapest)
  • Papp, Gyula (Szeged)
  • Pavlik, Gábor (Budapest)
  • Spät, András (Budapest)
  • Szabó, Gyula (Szeged)
  • Szelényi, Zoltán (Pécs)
  • Szollár, Lajos (Budapest)
  • Szücs, Géza (Debrecen)
  • Telegdy, Gyula (Szeged)
  • Toldi, József (Szeged)
  • Tósaki, Árpád (Debrecen)

 

International Editorial Board

  • R. Bauer (Jena)
  • W. Benjelloun (Rabat)
  • A. W. Cowley Jr. (Milwaukee)
  • D. Djuric (Belgrade)
  • C. Fry (London)
  • S. Greenwald (London)
  • O. Hänninen (Kuopio)
  • H. G. Hinghofer-Szalkay (Graz)
  • T. Hortobágyi (Groningen)
  • Gy. Kunos (Richmond)
  • M. Mahmoudian (Tehran)
  • T. Mano (Seki, Gifu)
  • G. Navar (New Orleans)
  • H. Nishino (Nagoya)
  • O. Petersen (Liverpool)
  • U. Pohl (Münich)
  • R. S. Reneman (Maastricht)
  • A. Romanovsky (Phoenix)
  • G. M. Rubanyi (Richmond)
  • T. Sakata (Oita)
  • A. Siddiqui (Karachi)
  • Cs. Szabo (Beverly)
  • E. Vicaut (Paris)
  • N. Westerhof (Amsterdam)
  • L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Physiology International
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: pi@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Social Science Citation Index

 

 

2020  
Total Cites 245
WoS
Journal
Impact Factor
2,090
Rank by Physiology 62/81 (Q4)
Impact Factor  
Impact Factor 1,866
without
Journal Self Cites
5 Year 1,703
Impact Factor
Journal  0,51
Citation Indicator  
Rank by Journal  Physiology 67/84 (Q4)
Citation Indicator   
Citable 42
Items
Total 42
Articles
Total 0
Reviews
Scimago 29
H-index
Scimago 0,417
Journal Rank
Scimago Physiology (medical) Q3
Quartile Score  
Scopus 270/1140=1,9
Scite Score  
Scopus Physiology (medical) 71/98 (Q3)
Scite Score Rank  
Scopus 0,528
SNIP  
Days from  172
sumbission  
to acceptance  
Days from  106
acceptance  
to publication  

2019  
Total Cites
WoS
137
Impact Factor 1,410
Impact Factor
without
Journal Self Cites
1,361
5 Year
Impact Factor
1,221
Immediacy
Index
0,294
Citable
Items
34
Total
Articles
33
Total
Reviews
1
Cited
Half-Life
2,1
Citing
Half-Life
9,3
Eigenfactor
Score
0,00028
Article Influence
Score
0,215
% Articles
in
Citable Items
97,06
Normalized
Eigenfactor
0,03445
Average
IF
Percentile
12,963
Scimago
H-index
27
Scimago
Journal Rank
0,267
Scopus
Scite Score
235/157=1,5
Scopus
Scite Score Rank
Physiology (medical) 73/99 (Q3)
Scopus
SNIP
0,38

 

Physiology International
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 632 EUR / 788 USD
Print + online subscription: 736 EUR / 920 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Physiology International
Language English
Size B5
Year of
Foundation
2006 (1950)
Publication
Programme
2021 Volume 108
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2498-602X (Print)
ISSN 2677-0164 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 161 4 8
Mar 2021 183 10 9
Apr 2021 355 3 3
May 2021 442 2 1
Jun 2021 480 1 1
Jul 2021 456 7 10
Aug 2021 0 0 0